BAXTER HEALTHCARE CORPORATION — Ondansetron Importer Profile
Pharmaceutical Importer · #17 buyer for Ondansetron · $1.2M import value · 31 shipments · UNITED STATES · DGFT Verified
BAXTER HEALTHCARE CORPORATION is the #17 importer of Ondansetron from India with $1.2M in import value and 31 verified shipments. BAXTER HEALTHCARE CORPORATION holds a 1.1% market share in Ondansetron imports based in UNITED STATES. The company sources from 1 verified supplier across 10 formulations shipped to 1 country. Overall, BAXTER HEALTHCARE CORPORATION imports 5 pharmaceutical products worth $11.8M across 5 therapeutic categories.
BAXTER HEALTHCARE CORPORATION — Ondansetron Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ondansetron to BAXTER HEALTHCARE CORPORATION?
Verified from 31 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED | $1.2M | 31 | 100.0% |
BAXTER HEALTHCARE CORPORATION sources Ondansetron from 1 verified Indian supplier based on 31 customs records. The primary supplier is BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED accounting for 100.0% of imports.
Where Does BAXTER HEALTHCARE CORPORATION Import Ondansetron To?
Destination countries from 31 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.2M | 31 | 100.0% |
BAXTER HEALTHCARE CORPORATION imports Ondansetron to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.2M.
What Ondansetron Formulations Does BAXTER HEALTHCARE CORPORATION Import?
| Formulation | Value | Shipments |
|---|---|---|
| ONDANSETRON INJ USP 2 MG/ML 2ML GVNOS | $367.9K | 12 |
| ONDANSETRON INJ USP 2 MG/ML 2ML GV AIN00 | $150.0K | 3 |
| ONDANSETRON INJECTION USP 2 MG/ML 2 ML GLASS VIAL | $141.1K | 3 |
| ONDANSETRON INJECTION USP 2 MG ML 2ML GLASS VIAL | $100.0K | 2 |
| ONDANSETRON INJ USP 2 MG/ML 2ML GV AIN00237 | $97.8K | 2 |
| ONDANSETRON INJECTION USP 2 MG/ML 2ML GL | $95.8K | 2 |
| ONDANSETRON INJ USP 2 MG/ML 2ML GV | $94.6K | 2 |
| ONDANSETRON INJ USP 2 MG/ML 2ML GV AIN00237NOS | $94.5K | 3 |
| ONDANSETRON INJECTION USP 2MG/ML 2ML GV | $50.0K | 1 |
| ONDANSETRON INJECTION USP 2 MG/ML 2ML G | $48.1K | 1 |
BAXTER HEALTHCARE CORPORATION imports 10 distinct Ondansetron formulations from India. The top formulation is ONDANSETRON INJ USP 2 MG/ML 2ML GVNOS with 12 shipments worth $367.9K.
Regulatory Requirements: Importing Ondansetron into United States
What BAXTER HEALTHCARE CORPORATION and other importers must comply with to import Ondansetron from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Ondansetron
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ondansetron from India and How Much Does BAXTER HEALTHCARE CORPORATION Import?
India exported $53.7M worth of Ondansetron through 8,469 shipments from 537 suppliers to 157 countries, serving 1,636 buyers globally. BAXTER HEALTHCARE CORPORATION imports $1.2M of this total, accounting for 1.1% of India's Ondansetron exports with 31 shipments from UNITED STATES. This is verified from 31 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for BAXTER HEALTHCARE CORPORATION's Ondansetron Imports?
BAXTER HEALTHCARE CORPORATION's average Ondansetron order value is $40.0K per consignment, based on 31 shipments totaling $1.2M. BAXTER HEALTHCARE CORPORATION is based in UNITED STATES and ranks #17 among all Ondansetron importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ondansetron to BAXTER HEALTHCARE CORPORATION?
BAXTER HEALTHCARE CORPORATION sources Ondansetron from 1 verified Indian supplier: BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ($1.2M, 100.0%). This is based on 31 customs records.
How Does BAXTER HEALTHCARE CORPORATION Compare to Other Ondansetron Importers?
BAXTER HEALTHCARE CORPORATION ranks #17 among 1,636 Ondansetron importers from India with a 1.1% market share. The top 3 importers are GLENMARK PHARMACEUTICALS INC., USA ($7.6M), AVET PHARMACEUTICALS INC ($5.5M), RISING PHARMA HOLDINGS, INC. ,. ($5.1M). BAXTER HEALTHCARE CORPORATION processed 31 shipments from UNITED STATES.
About BAXTER HEALTHCARE CORPORATION
BAXTER HEALTHCARE CORPORATION imports 5 products worth $11.8M. Beyond Ondansetron, top products include Ketorolac, Furosemide, Tobramycin, Verapamil. View the complete BAXTER HEALTHCARE CORPORATION profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ondansetron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ondansetron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BAXTER HEALTHCARE CORPORATION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BAXTER HEALTHCARE CORPORATION's capped import value divided by total capped export value for Ondansetron across all Indian exporters.
- 5.Verified Records: This page is backed by 31 individual customs records matching BAXTER HEALTHCARE CORPORATION importing Ondansetron, covering 10 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 157+ countries, 1,636+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ondansetron Import Data for BAXTER HEALTHCARE CORPORATION
Access order-level details, pricing data, supplier connections, and competitive analysis for BAXTER HEALTHCARE CORPORATION's Ondansetron imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BAXTER HEALTHCARE CORPORATION
Full Company Profile →
5 products · $11.8M total trade · 5 categories
BAXTER HEALTHCARE CORPORATION × Ondansetron
Verified from customs records
Company Overview
Top Products by BAXTER HEALTHCARE CORPORATION
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BAXTER HEALTHCARE CORPORATION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ondansetron. For current order-level data, contact TransData Nexus.